Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

Mechanisms of Ageing and Development

Volumn 155, Issue , 2016, Pages 10-21

  Yuan, Yujia ^a   Cruzat, Vinicius Fernandes ^b,c   Newshome, Philip ^b   Cheng, Jingqiu ^a   Chen, Younan ^a,b   Lu, Yanrong ^a  

^a SICHUAN UNIVERSITY   (China)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HIF 1 ; Oxidative phosphorylation; PGC 1 ; Reactive oxygen species

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHRL1; HIF1A PROTEIN, HUMAN; PPARGC1A PROTEIN, HUMAN; SIRT1 PROTEIN, HUMAN;

AGING; CELL FUNCTION; CYTOPLASM; DISEASE ASSOCIATION; HUMAN; HYPOXIA; MITOCHONDRIAL BIOGENESIS; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSCRIPTION REGULATION; UBIQUITINATION; ANIMAL; CELL AGING; GENETICS; METABOLISM; MITOCHONDRIAL DYNAMICS;

AGING; ANIMALS; CELL AGING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; SIRTUIN 1;

EID: 84959559301     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.02.003     Document Type: Review

References (140)

1. Abdelmohsen K., Pullmann R., Lai A., Kim H.H., Galban S., Yang X.L., Blethrow J.D., Walker M., Shubert J., Gillespie D.A., Furneaux H., Gorospe M. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 2007, 25:543-557.
2. Amat R., Planavila A., Chen S.L., Iglesias R., Giralt M., Villarroya F. SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. J. Biol. Chem. 2009, 284:1872-1880.
3. Aquilano K., Vigilanza P., Baldelli S., Pagliei B., Rotilio G., Ciriolo M.R. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J. Biol. Chem. 2010, 285:21590-21599.
4. Aquilano K., Baldelli S., Pagliei B., Ciriolo M.R. Extranuclear localization of SIRT1 and PGC-1: an insight into possible roles in diseases associated with mitochondrial dysfunction. Curr. Mol. Med. 2013, 13:140-154.
5. Arunachalam G., Samuel S.M., Marei I., Ding H., Triggle C.R. Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1. Br. J. Pharmacol. 2014, 171:523-535.
6. Back J.H., Rezvani H.R., Zhu Y.C., Guyonnet-Duperat V., Athar M., Ratner D., Kim A.L. Cancer cell survival following DNA damage-mediated premature senescence is regulated by mammalian target of rapamycin (mTOR)-dependent inhibition of sirtuin 1. J. Biol. Chem. 2011, 286:19100-19108.
7. Bai P., Canto C., Brunyanszki A., Huber A., Szanto M., Cen Y., Yamamoto H., Houten S.M., Kiss B., Oudart H., Gergely P., Menissier-de Murcia J., Schreiber V., Sauve A.A., Auwerx J. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab. 2011, 13:450-460.
8. Bai P., Canto C., Oudart H., Brunyanszki A., Cen Y.N., Thomas C., Yamamoto H., Huber A., Kiss B., Houtkooper R.H., Schoonjans K., Schreiber V., Sauve A.A., Menissier-de Murcia J., Auwerx J. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 2011, 13:461-468.
9. Bai B., Liang Y., Xu C., Lee M.Y., Xu A., Wu D., Vanhoutte P.M., Wang Y. Cyclin-dependent kinase 5-mediated hyperphosphorylation of sirtuin-1 contributes to the development of endothelial senescence and atherosclerosis. Circulation 2012, 126:729-740.
10. Baldelli S., Aquilano K., Ciriolo M.R. PGC-1alpha buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis. 2014, 5:e1515.
11. Bellafante E., Morgano A., Salvatore L., Murzilli S., Di Tullio G., D'Orazio A., Latorre D., Villani G., Moschetta A. PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine. PNAS 2014, 111:E4523-31.
12. Bereiter-Hahn J. Do we age because we have mitochondria?. Protoplasma 2014, 251:3-23.
13. Biala A.K., Dhingra R., Kirshenbaum L.A. Mitochondrial dynamics: orchestrating the journey to advanced age. J. Mol. Cell. Cardiol. 2015, 83:37-43.
14. Brenmoehl J., Hoeflich A. Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion 2013, 13:755-761.
15. Byles Vanessa, Chmilewski L.K., Wang Joyce, Zhu Lijia, Forman Lora W., Faller Douglas V., Dai Yan Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K IGF-1R signaling in human cancer cells. Int. J. Biol. Sci. 2010, 6:599-612.
16. Caito S., Rajendrasozhan S., Cook S., Chung S., Yao H.W., Friedman A.E., Brookes P.S., Rahman I. SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 2010, 24:3145-3159.
17. Calder P.C., Dimitriadis G., Newsholme P. Glucose metabolism in lymphoid and inflammatory cells and tissues. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:531-540.
18. Canto C., Gerhart-Hines Z., Feige J.N., Lagouge M., Noriega L., Milne J.C., Elliott P.J., Puigserver P., Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
19. Carabelli J., Burgueno A.L., Rosselli M.S., Gianotti T.F., Lago N.R., Pirola C.J., Sookoian S. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J. Cell. Mol. Med. 2011, 15:1329-1338.
20. Carelli V., Maresca A., Caporali L., Trifunov S., Zanna C., Rugolo M. Mitochondria: biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations. Int. J. Biochem. Cell Biol. 2015, 63:21-24.
21. Chen W.Y., Wang D.H., Yen R.C., Luo J., Gu W., Baylin S.B. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005, 123:437-448.
22. Chen R., Dioum E.M., Hogg R.T., Gerard R.D., Garcia J.A. Hypoxia increases sirtuin 1 expression in a hypoxia-inducible factor-dependent manner. J. Biol. Chem. 2011, 286:13869-13878.
23. Cho S.H., Chen J.A., Sayed F., Ward M.E., Gao F.Y., Nguyen T.A., Krabbe G., Sohn P.D., Lo I., Minami S., Devidze N., Zhou Y.G., Coppola G., Gan L. SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1 beta. J. Neurosci. 2015, 35:807-818.
24. Choi S.E., Fu T., Seok S., Kim D.H., Yu E., Lee K.W., Kang Y., Li X., Kemper B., Kemper J.K. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 2013, 12:1062-1072.
25. Chung S., Yao H., Caito S., Hwang J.W., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501:79-90.
26. Dehennaut V., Loison I., Dubuissez M., Nassour J., Abbadie C., Leprince D. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair. J. Biol. Chem. 2013, 288:10254-10264.
27. Deng S., Zhu S., Wang B., Li X., Liu Y., Qin Q., Gong Q., Niu Y., Xiang C., Chen J., Yan J., Deng S., Yin T., Yang M., Wu H., Wang C., Zhao G. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway. Cancer Lett. 2014, 355:184-191.
28. Dillon L.M., Rebelo A.P., Moraes C.T. The role of PGC-1 coactivators in aging skeletal muscle and heart. IUBMB Life 2012, 64:231-241.
29. Dillon L.M., Williams S.L., Hida A., Peacock J.D., Prolla T.A., Lincoln J., Moraes C.T. Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum. Mol. Genet. 2012, 21:2288-2297.
30. Dixit D., Sharma V., Ghosh S., Mehta V.S., Sen E. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition. Cell Death Dis. 2012, 9:e271.
31. Donmez G., Arun A., Chung C.Y., McLean P.J., Lindquist S., Guarente L. SIRT1 protects against alpha-Synuclein aggregation by activating molecular chaperones. J. Neurosci. 2012, 32:124-132.
32. Fang E.F., Scheibye-Knudsen M., Brace L.E., Kassahun H., SenGupta T., Nilsen H., Mitchell J.R., Croteau D.L., Bohr V.A. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD(+)/SIRT1 reduction. Cell 2014, 157:882-896.
33. Fentz J., Kjøbsted R., Birk J.B., Jordy A.B., Jeppesen J., Thorsen K., Schjerling P., Kiens B., Jessen N., Viollet B., Wojtaszewski J.F. AMPKα is critical for enhancing skeletal muscle fatty acid utilization during in vivo exercise in mice. FASEB J. 2015, 29:1725-1738.
34. Ford J., Ahmed S., Allison S., Jiang M., Milner J. JNK2-dependent regulation of SIRT1 protein stability. Cell Cycle 2008, 7:3091-3097.
35. Frye R.A. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem. Biophys. Res. Commun. 2000, 273:793-798.
36. 2 accelerates cellular senescence by accumulation of acetylated p53 via decrease in the function of SIRT1 by NAD(+) depletion. Cell. Physiol. Biochem. 2007, 20:45-54.
37. Fusco S., Ripoli C., Podda M.V., Ranieri S.C., Leone L., Toietta G., McBurney M.W., Schutz G., Riccio A., Grassi C., Galeotti T., Pani G. A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:621-626.
38. Gano L.B., Donato A.J., Pasha H.M., Hearon C.M., Sindler A.L., Seals D.R. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction excessive superoxide production, and inflammation with aging in mice. Am. J. Physiol. Heart Circ. Physiol. 2014, 307:H1754-H1763.
39. Gao J., Wang Y., Zhao X., Chen P., Xie L. MicroRNA-204-5p-mediated regulation of SIRT1 contributes to the delay of epithelial cell cycle traversal in diabetic corneas. Investig. Ophthalmol. Vis. Sci. 2015, 56:1493-1504.
40. Gao Z.G., Zhang J., Kheterpal I., Kennedy N., Davis R.J., Ye J.P. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J. Biol. Chem. 2011, 286:22227-22234.
41. García-Prieto C.F., Gil-Ortega M., Aránguez I., Ortiz-Besoain M., Somoza B., Fernández-Alfonso M.S. Vascular AMPK as an attractive target in the treatment of vascular complications of obesity. Vasc. Pharmacol. 2015, 67-69:10-20.
42. Gaziev A.I., Abdullaev S., Podlutsky A. Mitochondrial function and mitochondrial DNA maintenance with advancing age. Biogerontology 2014, 15:417-438.
43. Gomes A.P., Price N.L., Ling A.J., Moslehi J.J., Montgomery M.K., Rajman L., White J.P., Teodoro J.S., Wrann C.D., Hubbard B.P., Mercken E.M., Palmeira C.M., de Cabo R., Rolo A.P., Turner N., Bell E.L., Sinclair D.A. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 2013, 155:1624-1638.
44. Gong H., Pang J., Han Y.W., Dai Y., Dai D.P., Cai J.P., Zhang T.M. Age-dependent tissue expression patterns of Sirt1 in senescence-accelerated mice. Mol. Med. Rep. 2014, 10:3296-3302.
45. Gradin K., McGuire J., Wenger R.H., Kvietikova I., Whitelaw M.L., Toftgard R., Tora L., Gassmann M., Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 1996, 16:5221-5231.
46. Guo X., Wu Y., Hartley R.S. MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 2009, 6:575-583.
47. Han L., Zhou R., Niu J., McNutt M.A., Wang P., Tong T. SIRT1 is regulated by a PPAR-SIRT1 negative feedback loop associated with senescence. Nucleic Acids Res. 2010, 38:7458-7471.
48. Herrmann J., Lerman L.O., Lerman A. Ubiquitin and ubiquitin-like proteins in protein regulation. Circ. Res. 2007, 100:1276-1291.
49. Herskovits A.Z., Guarente L. SIRT1 in neurodevelopment and brain senescence. Neuron 2014, 81:471-483.
50. Hwang J.W., Yao H., Caito S., Sundar I.K., Rahman I. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic. Biol. Med. 2013, 61:95-110.
51. Ito T., Yagi S., Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
52. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12017-12022.
53. Ji K., Zheng J., Lv J., Xu J., Ji X., Luo Y.B., Li W., Zhao Y., Yan C. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1alpha pathway. Free Radic. Biol. Med. 2015, 84:161-170.
54. Jin Q., Yan T., Ge X., Sun C., Shi X., Zhai Q. Cytoplasm-localized SIRT1 enhances apoptosis. J. Cell. Physiol. 2007, 213:88-97.
55. Kang H., Jung J.W., Kim M.K., Chung J.H. CK2 Is the regulator of SIRT1 substrate-binding affinity, deacetylase activity and cellular response to DNA-damage. PLoS One 2009, 4:e6611.
56. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G.C., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
57. Kim S., Kim M.J., Park D.Y., Chung H.J., Kim C.H., Yoon J.H., Kim H.J. Mitochondrial reactive oxygen species modulate innate immune response to influenza A virus in human nasal epithelium. Antivir. Res. 2015, 119:78-83.
58. Kornberg M.D., Sen N., Hara M.R., Juluri K.R., Nguyen J.V.K., Snowman A.M., Law L., Hester L.D., Snyder S.H. GAPDH mediates nitrosylation of nuclear proteins. Nat. Cell Biol. 2010, 12. 1094-U89.
59. Kuo C.Y., Chiu Y.C., Lee A.Y., Hwang T.L. Mitochondrial Lon protease controls ROS-dependent apoptosis in cardiomyocyte under hypoxia. Mitochondrion 2015, 23:7-16.
60. LaRocca T.J., Hearon C.M., Henson G.D., Seals D.R. Mitochondrial quality control and age-associated arterial stiffening. Exp. Gerontol. 2014, 58:78-82.
61. Lee H.C., Wei Y.H. Mitochondria and aging. Adv. Exp. Med. Biol. 2012, 942:311-327.
62. Li N., Muthusamy S., Liang R.Q., Sarojini H., Wang E. Increased expression of miR-34a and miR-93 in rat liver during aging: and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 2011, 132:75-85.
63. Li Y., He L., Zeng N., Sahu D., Cadenas E., Shearn C., Li W., Stiles B.L. Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) signaling regulates mitochondrial biogenesis and respiration via estrogen-related receptor alpha (ERRalpha). J. Biol. Chem. 2013, 288:25007-25024.
64. Li D., Li X., Guan Y., Guo X. Mitofusin-2-mediated tethering of mitochondria and endoplasmic reticulum promotes cell cycle arrest of vascular smooth muscle cells in G0/G1 phase. Acta Biochim. Biophys. Sin. (Shanghai) 2015, 47:441-450.
65. Li L., Sun Q., Li Y., Yang Y., Yang Y., Chang T., Man M., Zheng L. Overexpression of SIRT1 induced by resveratrol and inhibitor of miR-204 suppresses activation and proliferation of microglia. J. Mol. Neurosci. 2015, 56:858-867.
66. Lin C.H., Lin C.C., Ting W.J., Pai P.Y., Kuo C.H., Ho T.J., Kuo W.W., Chang C.H., Huang C.Y., Lin W.T. Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3 K/Akt signaling to improve the effects of exercise in elderly rat hearts. Age (Dordr) 2014, 36:9705.
67. Lin J.R., Shen W.L., Yan C., Gao P.J. Downregulation of dynamin-related protein 1 contributes to impaired autophagic flux and angiogenic function in senescent endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2015, 35:1413-1422.
68. Little J.P., Safdar A., Wilkin G.P., Tarnopolsky M.A., Gibala M.J. A practical model of low-volume high-intensity interval training induces mitochondrial biogenesis in human skeletal muscle: potential mechanisms. J. Physiol. 2010, 588:1011-1022.
69. Liu X.Y., Wang D.L., Zhao Y., Tu B., Zheng Z.X., Wang L.N., Wang H.Y., Gu W., Roeder R.G., Zhu W.G. Methyltransferase Set7/9 regulates p53 activity by interacting with sirtuin 1 (SIRT1). Proc. Natl. Acad. Sci. U. S. A. 2011, 108:1925-1930.
70. Liu Z., Liu Y., Gao R., Li H., Dunn T., Wu P., Smith R.G., Sarkar P.S., Fang X. Ethanol suppresses PGC-1α expression by interfering with the cAMP-CREB pathway in neuronal cells. PLoS One 2014, 9:e104247.
71. Lopez-Lluch G., Irusta P.M., Navas P., de Cabo R. Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 2008, 43:813-819.
72. Luo J., Li M., Tang Y., Laszkowska M., Roeder R.G., Gu W. Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:2259-2264.
73. Lutzner N., Arce J.D., Rosl F. Gene expression of the tumour suppressor LKB1 is mediated by Sp1, NF-Y and FOXO transcription factors. PLoS One 2012, 7:e32590.
74. Marasa B.S., Srikantan S., Martindale J.L., Kim M.M., Lee E.K., Gorospe M., Abdelmohsen K. MicroRNA profiling in human diploid fibroblasts uncovers miR-519 role in replicative senescence. Aging (Albany NY) 2010, 2:333-343.
75. Mendelsohn A.R., Larrick J.W. Partial reversal of skeletal muscle aging by restoration of normal NAD(+) levels. Rejuvenation Res. 2014, 17:62-69.
76. Menzies K.J., Hood D.A. The role of SirT1 in muscle mitochondrial turnover. Mitochondrion 2012, 12:5-13.
77. Michishita E., Park J.Y., Burneskis J.M., Barrett J.C., Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol. Biol. Cell 2005, 16:4623-4635.
78. Mohamed J.S., Wilson J.C., Myers M.J., Sisson K.J., Alway S.E. Dysregulation of SIRT-1 in aging mice increases skeletal muscle fatigue by a PARP-1-dependent mechanism. Aging (Albany NY) 2014, 6:820-834.
79. Morgan D., Oliveira-Emilio H.R., Keane D., Hirata A.E., da Rocha M.S., Bordin S., Curi R., Newsholme P., Carpinelli A.R. Glucose: palmitate and pro-inflammatory cytokines modulate production and activity of a phagocyte-like NADPH oxidase in rat pancreatic islets and a clonal beta cell line. Diabetologia 2007, 50:359-369.
80. Morris B.J. Seven sirtuins for seven deadly diseases of aging. Free Radic. Biol. Med. 2013, 56:133-171.
81. Moynihan K.A., Grimm A.A., Plueger M.M., Bernal-Mizrachi E., Ford E., Cras-Meneur C., Permutt M.A., Imai S.I. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metab. 2005, 2:105-117.
82. Nasrin N., Kaushik V.K., Fortier E., Wall D., Pearson K.J., de Cabo R., Bordone L. JNK1 phosphorylates SIRT1 and promotes its enzymatic activity. PLoS One 2009, 4:e8414.
83. Nemoto S., Fergusson M.M., Finkel T. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 2004, 306:2105-2108.
84. Newsholme F., Curi R., Curi T.C.P., Murphy C.J., Garcia C., de Melo M.P. Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease. J. Nutri. Biochem. 1999, 10:316-324.
85. Noriega L.G., Feige J.N., Canto C., Yamamoto H., Yu J.J., Herman M.A., Mataki C., Kahn B.B., Auwerx J. CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability. EMBO Rep. 2011, 12:1069-1076.
86. O'Neill H.M., Lally J.S., Galic S., Thomas M., Azizi P.D., Fullerton M.D., Smith B.K., Pulinilkunnil T., Chen Z.P., Samaan M.C., Jorgensen S.B., Dyck J.R.B., Holloway G.P., Hawke T.J., van Denderen B.J., Kemp B.E., Steinberg G.R. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 2014, 57:1693-1702.
87. Okazaki M., Iwasaki Y., Nishiyama M., Taguchi T., Tsugita M., Nakayama S., Kambayashi M., Hashimoto K., Terada Y. PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. Endocr. J. 2010, 57:403-413.
88. Pang L.J., Tian H.Y., Chang N., Yi J., Xue L.X., Jiang B., Gorospe M., Zhang X.W., Wang W.G. Loss of CARM1 is linked to reduced HuR function in replicative senescence. BMC Mol. Biol. 2013, 14. article 15.
89. Paz J.C., Park S.H., Phillips N., Matsumura S., Tsai W.W., Kasper L., Brindle P.K., Zhang G.T., Zhou M.M., Wright P.E., Montminy M. Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:17116-17121.
90. Peng C., Ma J., Gao X., Tian P., Li W., Zhang L. High glucose induced oxidative stress and apoptosis in cardiac microvascular endothelial cells are regulated by FoxO3a. PLoS One 2013, 8:e79739.
91. Peterson C.M., Johannsen D.L., Ravussin E. Skeletal muscle mitochondria and aging: a review. J. Aging Res. 2012, 2012:194821.
92. Picca A., Pesce V., Fracasso F., Joseph A.M., Leeuwenburgh C., Lezza A.M.S. Aging and calorie restriction oppositely affect mitochondrial biogenesis through TFAM binding at both origins of mitochondrial DNA replication in rat liver. PLoS One 2013, 8:e74644.
93. Pramanik D., Campbell N.R., Karikari C., Chivukula R., Kent O.A., Mendell J.T., Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol. Cancer Ther. 2011, 10:1470-1480.
94. Purushotham A., Schug T.T., Xu Q., Surapureddi S., Guo X.M., Li X.L. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009, 9:327-338.
95. Qin Z.Y., Zhang M., Dai Y.M., Wang Y.M., Zhu G.Z., Zhao Y.P., Ji C.B., Qiu J., Cao X.G., Guo X.R. Metformin prevents LYRM1-induced insulin resistance in 3T3-L1 adipocytes via a mitochondrial-dependent mechanism. Exp. Biol. Med. 2014, 239:1567-1574.
96. Radogna F., Albertini M.C., De Nicola M., Diederich M., Bejarano I., Ghibelli L. Melatonin promotes Bax sequestration to mitochondria reducing cell susceptibility to apoptosis via the lipoxygenase metabolite 5-hydroxyeicosatetraenoic acid. Mitochondrion 2015, 21:113-121.
97. Ramachandran D., Roy U., Garg S., Ghosh S., Pathak S., Kolthur-Seetharam U. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets. FEBS J. 2011, 278:1167-1174.
98. Ramis M.R., Esteban S., Miralles A., Tan D.X., Reiter R.J. Caloric restriction, resveratrol and melatonin: Role of SIRT1 and implications for aging and related-diseases. Mech. Ageing Dev. 2015, 146-148:28-41.
99. Revollo J.R., Li X.L. The ways and means that fine tune Sirt1 activity. Trends Biochem. Sci. 2013, 38:160-167.
100. Rodgers J.T., Lerin C., Gerhart-Hines Z., Puigserver P. Metabolic adaptations through the PGC-1 alpha and SIRT1 pathways. FEBS Lett. 2008, 582:46-53.
101. Rogers R.P., Rogina B. Increased mitochondrial biogenesis preserves intestinal stem cell homeostasis and contributes to longevity in Indy mutant flies. Aging (Albany NY) 2014, 6:335-350.
102. Romano A.D., Greco E., Vendemiale G., Serviddio G. Bioenergetics and mitochondrial dysfunction in aging: recent insights for a therapeutical approach. Curr. Pharm. Des. 2014, 20:2978-2992.
103. Rosenberg M.I., Parkhurst S.M. Drosophila Sir2 is required for heterochromatic silencing and by euchromatic Hairy/E(Spl) bHLH repressors in segmentation and sex determination. Cell 2002, 109:447-458.
104. Salvadó Laia, Barroso Emma, Gómez-Foix Anna Maria, Palomer Xavier, Michalik Liliane, Wahli Walter, Vázquez-Carrera M. PPARó/á prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism. Diabetologia 2014, 57:2126-2135.
105. Sasaki T., Maier B., Koclega K.D., Chruszcz M., Gluba W., Stukenberg P.T., Minor W., Scrable H. Phosphorylation regulates SIRT1 function. PLoS One 2008, 3:e4020.
106. Satoh A., Brace C.S., Rensing N., Cliften P., Wozniak D.F., Herzog E.D., Yamada K.A., Imai S. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 2013, 18:416-430.
107. Scarpulla R.C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 2011, 1813:1269-1278.
108. Schmeisser K., Mansfeld J., Kuhlow D., Weimer S., Priebe S., Heiland I., Birringer M., Groth M., Segref A., Kanfi Y., Price N.L., Schmeisser S., Schuster S., Pfeiffer A.F.H., Guthke R., Platzer M., Hoppe T., Cohen H.Y., Zarse K., Sinclair D.A., Ristow M. Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide. Nat. Chem. Biol. 2013, 9:693.
109. Schonrock N., Humphreys D.T., Preiss T., Gotz J. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-beta. J. Mol. Neurosci. 2012, 46:324-335.
110. Shaw R.J., Kosmatka M., Bardeesy N., Hurley R.L., Witters L.A., DePinho R.A., Cantley L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3329-3335.
111. Sin T.K., Yu A.P., Yung B.Y., Yip S.P., Chan L.W., Wong C.S., Ying M., Rudd J.A., Siu P.M. Modulating effect of SIRT1 activation induced by resveratrol on Foxo1-associated apoptotic signalling in senescent heart. J. Physiol. 2014, 592:2535-2548.
112. St-Pierre J., Drori S., Uldry M., Silvaggi J.M., Rhee J., Jager S., Handschin C., Zheng K., Lin J., Yang W., Simon D.K., Bachoo R., Spiegelman B.M. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
113. Stankovic-Valentin N., Deltour S., Seeler J., Pinte S., Vergoten G., Guerardel C., Dejean A., Leprince D. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 2007, 27:1675-2661.
114. Sudheesh N.P., Ajith T.A., Janardhanan K.K., Krishnan C.V. Palladium alpha-lipoic acid complex formulation enhances activities of Krebs cycle dehydrogenases and respiratory complexes I-IV in the heart of aged rats. Food Chem. Toxicol. 2009, 47:2124-2128.
115. Tanno M., Sakamoto J., Miura T., Shimamoto K., Horio Y. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J. Biol. Chem. 2007, 282:6823-6832.
116. Tarantino C., Paolella G., Cozzuto L., Minopoli G., Pastore L., Parisi S., Russo T. miRNA 34a 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J. 2010, 24:3255-3263.
117. Tong C., Morrison A., Mattison S., Qian S., Bryniarski M., Rankin B., Wang J., Thomas D.P., Li J. Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress. FASEB J. 2013, 27:4332-4342.
118. Tran D., Bergholz J., Zhang H.B., He H.B., Wang Y., Zhang Y.J., Li Q.T., Kirkland J.L., Xiao Z.X. Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence. Aging Cell 2014, 13:669-678.
119. Ungvari Z., Sonntag W.E., Csiszar A. Mitochondria and aging in the vascular system. J. Mol. Med. (Berl.) 2010, 88:1021-1027.
120. Valli A., Harris A.L., Kessler B.M. Hypoxia metabolism in ageing. Aging (Albany NY) 2015, 7:465-466.
121. van der Veer E., Ho C., O'Neil C., Barbosa N., Scott R., Cregan S.P., Pickering J.G. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase. J. Biol. Chem. 2007, 282:10841-10845.
122. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001, 107:149-159.
123. Vinciguerra M., Santini M.P., Martinez C., Pazienza V., Claycomb W.C., Giuliani A., Rosenthal N. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 2012, 11:139-149.
124. Wang C., Chen L., Hou X., Li Z., Kabra N., Ma Y., Nemoto S., Finkel T., Gu W., Cress W.D., Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 2006, 8:1025-1031.
125. Wang R.S., Li J.J., Diao S.Y., Kwak Y.D., Liu L., Zhi L.T., Bueler H., Bhat N.R., Williams R.W., Park E.A., Liao F.F. Metabolic stress modulates alzheimer's beta-secretase gene transcription via SIRT1-PPAR gamma-PGC-1 in neurons. Cell Metab. 2013, 17:685-694.
126. Wang Y., Zhao X., Lotz M., Terkeltaub R., Liu-Bryan R. Mitochondrial biogenesis is impaired in osteoarthritic chondrocytes but reversible via peroxisome proliferator-activated receptor-γ coactivator 1α. Arthritis Rheumatol. 2015, 67:2141-2153.
127. Wenz T. Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion 2013, 13:134-142.
128. Xiong S., Salazar G., Patrushev N., Alexander R.W. FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 2011, 286:5289-5299.
129. Xu D., Takeshita F., Hino Y., Fukunaga S., Kudo Y., Tamaki A., Matsunaga J., Takahashi R.U., Takata T., Shimamoto A., Ochiya T., Tahara H. miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 2011, 193:409-424.
130. Xu F., Zhang X.T., Lei Y.T., Liu X.W., Liu Z.Y., Tong T.J., Wang W.G. Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma. J. Cell. Biochem. 2010, 111:727-734.
131. Xu Q., Xia P., Li X., Wang W., Liu Z., Gao X. Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis. PLoS One 2014, 9:e88243.
132. Yao H., Chung S., Hwang J.W., Rajendrasozhan S., Sundar I.K., Dean D.A., McBurney M.W., Guarente L., Gu W., Ronty M., Kinnula V.L., Rahman I. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. J. Clin. Investig. 2012, 122:2032-2045.
133. Yao H., Rahman I. Perspectives on translational and therapeutic aspects of SIRT1 in inflammaging and senescence. Biochem. Pharmacol. 2012, 84:1332-1339.
134. Zhang Q., Wang S.Y., Fleuriel C., Leprince D., Rocheleau J.V., Piston D.W., Goodman R.H. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:829-833.
135. Zhang S.C., Liu L., Wang R.J., Tuo H.Z., Guo Y.J., Yi L., Wang D.X., Wang J.W. MicroRNA-217 promotes angiogenesis of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and FOXO3A. PLoS One 2013, 8:e83620.
136. Zhang S.C., Liu L., Wang R.J., Tuo H.Z., Guo Y.J., Yi L., Wang J.W., Wang D.X. MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS. Arch. Virol. 2013, 158:2443-2452.
137. Zhang L.W., Huang D.S., Wang Q.S., Shen D., Wang Y.M., Chen B.Y., Zhang J.Q., Gai L.Y. MiR-132 inhibits expression of SIRT1 and induces pro-inflammatory processes of vascular endothelial inflammation through blockade of the SREBP-1c metabolic pathway. Cardiovasc. Drugs Ther. 2014, 28:303-311.
138. Zhong L., Mostoslavsky R. Fine tuning our cellular factories: sirtuins in mitochondrial biology. Cell Metab. 2011, 13:621-626.
139. Zhu H.Q., Yang Y.X., Wang Y.P., Li J.M., Schiller P.W., Peng T.Q. MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res. 2011, 92:75-84.
140. Zschoernig B., Mahlknecht U. Carboxy-terminal phosphorylation of SIRT1 by protein kinase CK2. Biochem. Biophys. Res. Commun. 2009, 381:372-377.